Dualyx logo

Dualyx

Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases.

6 employees · est. 2021 · Belgium

VS
RareSum logo

RareSum

Empowering Healthcare Professionals with AI-powered research and decision-support solutions for Rare Diseases.

9 employees · est. 2024 · Istanbul, Turkey

Dualyx is the older company (2021 vs 2024).

Side-by-Side Comparison

Dualyx RareSum
Founded
2021 older 2024
Headquarters
Belgium Istanbul, Turkey
Employees
6 9
Industry
Biotechnology, Health Care AI, Health Care, SaaS
Funding Stage
Series A Unknown
Total Funding
$40.00M $50.00K
Funding Rounds
2 2
Services
Not tracked yet AI-Powered Research and Decision Support Tools, Medical Data Analysis and Screening, Clinical Decision Support for Rare Diseases, Customized NLP and Algorithm Development, Research and Industry Collaboration Framework
Target Customers
Not tracked yet Physicians, Healthcare Providers, Research Centers, Pharmaceutical Companies, Medical Laboratories, Insurance Companies
Taxonomy
Biologicals, Autoimmune Diseases, Rare Diseases, Drug Discovery, Therapeutic Innovation, Biopharmaceuticals, Medical Treatment, Patient Care, Unmet Medical Needs, Clinical Development, Healthcare Innovation AI-powered Decision Support, Rare Diseases, Research Efficiency, Diagnostic Process Acceleration, Data-driven Solutions, Healthcare Professionals Empowerment, User-friendly Tools, Algorithmic Approaches, Healthcare Partnerships, Advanced Data Technologies, Resource Optimization, Healthcare Stakeholders
Website
dualyx.com raresum.com
Dualyx logo

About Dualyx

Dualyx, established in 2021 and headquartered in Belgium, is a dynamic player in the Biotechnology and Health Care industries. The company is centered around the discovery and development of highly innovative biologicals designed to treat autoimmune and rare diseases, addressing high unmet medical n...

RareSum logo

About RareSum

RareSum, founded in 2024 and headquartered in Turkey, is making strides in the intersection of AI, Health Care, and SaaS industries. With its slogan, "Empowering Healthcare Professionals with AI-powered research and decision-support solutions for Rare Diseases," RareSum positions itself as a pivotal...

We will tell you when either one moves

BounceWatch watches Dualyx and RareSum for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Dualyx and RareSum — by email.

Frequently Asked Questions

Dualyx — Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases.. RareSum — Empowering Healthcare Professionals with AI-powered research and decision-support solutions for Rare Diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Dualyx has raised $40.00M while RareSum has raised $50.00K.
Dualyx and RareSum operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Dualyx with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Dualyx on 11 Sep 2024, and RareSum on 31 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy